Recursion Pharmaceuticals, Inc.(RXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RXRX Recursion Pharmaceuticals, Inc.

Post-Mkt 09-24 16:28:48 EDT

3.89

+0.19

+5.14%

盘后3.87

-0.02-0.49%

16:25 EDT

High3.90	Low3.61	Vol19.09M
Open3.65	D1 Closing3.70	Amplitude7.84%
Mkt Cap2.08B	Tradable Cap2.03B	Total Shares535.00M
T/O71.71M	T/O Rate3.65%	Tradable Shares522.33M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RXRX","market":"US","secType":"STK","nameCN":"Recursion Pharmaceuticals, Inc.","latestPrice":3.89,"timestamp":1790280000000,"preClose":3.7,"halted":0,"volume":19088254,"hourTrading":{"tag":"盘后","latestPrice":3.8709,"preClose":3.89,"latestTime":"16:25 EDT","volume":297699,"amount":1157768.8561614,"timestamp":1790281551524,"change":-0.0191,"changeRate":-0.00491,"amplitude":0.012853},"delay":0,"changeRate":0.05135135135135133,"floatShares":522325546,"shares":534999999,"eps":-1.021913,"marketStatus":"Post-Mkt","change":0.19,"latestTime":"09-24 16:28:48 EDT","open":3.65,"high":3.9,"low":3.61,"amount":71711924.6459956,"amplitude":0.078378,"askPrice":3.89,"askSize":376,"bidPrice":3.87,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.021913,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790294400000},"marketStatusCode":4,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":3.7,"preHourTrading":{"tag":"盘前","latestPrice":3.66,"preClose":3.7,"latestTime":"09:29 EDT","volume":94860,"amount":347168.05884,"timestamp":1790256592737,"change":-0.04,"changeRate":-0.010811,"amplitude":0.018919},"postHourTrading":{"tag":"盘后","latestPrice":3.8709,"preClose":3.89,"latestTime":"16:25 EDT","volume":297699,"amount":1157768.8561614,"timestamp":1790281551524,"change":-0.0191,"changeRate":-0.00491,"amplitude":0.012853},"volumeRatio":0.54714,"impliedVol":0.9093,"impliedVolPercentile":0.6016},"requestUrl":"/m/hq/s/RXRX/","defaultTab":"news","newsList":[{"id":"2669162636","title":"Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162636","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669162636?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:18","pubTimestamp":1790007493,"startTime":"0","endTime":"0","summary":"Recursion licenses TxFM RNA foundation model to Tempus AI for oncology use in USD 12 million dealRecursion Pharmaceuticals expanded its data partnership with Tempus AI, extending the term to six years","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL7Y7sX8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","TEM","ARKG","BK4539","BK4611","BK4613","BK4139","TEMT","LU1861559042.SGD","BK4548","BK4121","BK4609","LU1861558580.USD","TEMC","RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669162688","title":"Tempus Extends Data Licensing Partnership with Recursion Through November 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162688","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669162688?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:17","pubTimestamp":1790007444,"startTime":"0","endTime":"0","summary":"Tempus extends data licensing partnership with Recursion through November 2029Tempus extended its multi-year data license partnership with Recursion through November 2029.Deal resets original master a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL8vkn23:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","BK4611","LU1861558580.USD","HEAL","TEMC","BK4609","LU1861559042.SGD","RXRX","BK4139","BK4548","BK4613","BK4539","TEM","TEMT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669161540","title":"Tempus AI, Recursion Extend Data License, Amend Fee Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669161540","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669161540?lang=en_us&edition=fundamental","pubTime":"2026-09-21 22:36","pubTimestamp":1790001417,"startTime":"0","endTime":"0","summary":"Tempus AI  and Recursion Pharmaceuticals  extended their data license agreement through November 2029 and revised the contract's fee structure.Up to $84 million in discretionary payments over the next two years will be replaced with $42 million in committed payments over three years, Tempus said Monday in a statement.Tempus said it also signed a separate agreement granting the company a nonexclusive, worldwide license to Recursion's proprietary RNA sequencing model.Tempus shares rose 1.8% in Monday trading, and Recursion climbed 2.6%.Price: 79.27, Change: +1.43, Percent Change: +1.83","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4609","TEMC","TEM","BK4548","BK4539","BK4613","LU1861558580.USD","ARKG","LU1861559042.SGD","RXRX","TEMT","HEAL","BK4121","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169875","title":"Recursion, Tempus Expand AI and RNA Collaboration Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169875","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169875?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:29","pubTimestamp":1789997370,"startTime":"0","endTime":"0","summary":"The latest update is out from Recursion Pharmaceuticals ( ($RXRX) ). On September 15, 2026, Recursion Pharmaceuticals amended its long-term data an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEM","RXRX","BK4539","BK4121","BK4609","LU1861559042.SGD","TEMC","TEMT","BK4548","BK4139","ARKG","LU1861558580.USD","BK4613","HEAL","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169889","title":"Tempus AI, Recursion extend data license agreement, enter new license agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169889?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:20","pubTimestamp":1789996814,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced an extension of its data license agreement with Recursion Pharmaceuticals (RXRX). Additionally, the two companies have en...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4609","TEMC","TEMT","BK4548","BK4611","HEAL","LU1861558580.USD","LU1861559042.SGD","TEM","BK4539","BK4613","RXRX","BK4121","BK4139","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669666681","title":"Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm","url":"https://stock-news.laohu8.com/highlight/detail?id=2669666681","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669666681?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RXRX","HEAL","BK4613","ARKG","BK4611","LU1861559042.SGD","TEMT","BK4548","BK4139","TEMC","TEM","BK4539","BK4121","BK4609","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166574","title":"Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s Rna Foundation Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166574?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4613","TEMC","TEMT","TEM","RXRX","BK4548","BK4121","BK4539","BK4139","ARKG","BK4609","BK4611","HEAL","LU1861558580.USD","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166572","title":"Tempus AI, -Co and Recursion Extend Data Partnership Through November 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166572","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166572?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RXRX","TEMC","TEMT","TEM","LU1861558580.USD","BK4609","BK4548","BK4611","BK4139","LU1861559042.SGD","HEAL","BK4539","BK4613","BK4121","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669663671","title":"Recursion Pharmaceuticals - Enters Amendment to Master Agreement with Tempus on Sept 15, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669663671","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669663671?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:06","pubTimestamp":1789995986,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0BP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4609","BK4548","BK4539","RXRX","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166362","title":"Recursion Pharmaceuticals - Eliminates Co's Right to Terminate Agreement for Convenience - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166362","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166362?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:06","pubTimestamp":1789995986,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0BP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4609","BK4611","BK4548","BK4539","BK4139","RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166360","title":"Recursion Pharmaceuticals - Extends Agreement Term from Five to Six Years - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166360?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:06","pubTimestamp":1789995986,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0BP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RXRX","BK4609","BK4548","BK4611","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999378","title":"Recursion’s REC-7735 Trial: Early Precision Oncology Data That Could Move RXRX","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999378","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999378?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662635,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals, Inc ($RXRX) announced an update on their ongoing clinical study. Recursion Pharmaceuticals Inc. is running a Phase 1 / 2...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recursions-rec-7735-trial-early-precision-oncology-data-that-could-move-rxrx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recursions-rec-7735-trial-early-precision-oncology-data-that-could-move-rxrx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","BK4548","BK4139","BK4609","RXRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667962947","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Recursion Pharmaceuticals (RXRX), Teladoc (TDOC) and Oscar Health (OSCR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667962947","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667962947?lang=en_us&edition=fundamental","pubTime":"2026-09-16 01:40","pubTimestamp":1789494023,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Recursion Pharmaceuticals (RXRX), Teladoc (TDOC) a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-recursion-pharmaceuticals-rxrx-teladoc-tdoc-and-oscar-health-oscr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-recursion-pharmaceuticals-rxrx-teladoc-tdoc-and-oscar-health-oscr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","BK4588","BK4548","BK4504","BK4539","TDOC","LU1861558580.USD","BK4162","RXRX","BK4611","BK4567","BK4585","OSCX","LU1861559042.SGD","BK4139","HEAL","BK4551","OSCR","BK4609","BK4167","OSCG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666851602","title":"Recursion Pharma CEO Najat Khan Sells 22,408 Shares for $78,822","url":"https://stock-news.laohu8.com/highlight/detail?id=2666851602","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666851602?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:56","pubTimestamp":1789077394,"startTime":"0","endTime":"0","summary":"Recursion Pharma CEO Najat Khan sells 22,408 shares for $78,822Recursion Pharmaceuticals CEO and President Najat Khan sold 22,408 Class A common shares on Sep. 8, 2026.Sale priced at USD 3.52 per shar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL810t6S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Recursion Pharma CEO Najat Khan Sells 22,408 Shares for $78,822","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4548","RXRX","BK4539","BK4609","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191932836","title":"Arm's Haas: AI Could Cure Cancer In Our Lifetime — If The Industry Can Build Enough Chips","url":"https://stock-news.laohu8.com/highlight/detail?id=1191932836","media":"AI Industry Frontlines","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191932836?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:40","pubTimestamp":1788860424,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"https://static.tigerbbs.com/05500e88dd35c02215454aab95952bea","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/05500e88dd35c02215454aab95952bea"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Arm's Haas: AI Could Cure Cancer In Our Lifetime — If The Industry Can Build Enough Chips","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABSI","CRSP","TEM","BEAM","DNA","TEMC","TEMT","TXG","RBOT","RXRX"],"isVideo":true,"video":{"duration":73,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/1029/render_1029_1788859287938.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/1029.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/1029/tts/voiceover_643e356a105563d1.mp3","isAI":true},"gpt_icon":0},{"id":"2664423048","title":"Recursion Pharma Director Blake Borgeson Disposes of 30,000 Shares Valued at $100,200","url":"https://stock-news.laohu8.com/highlight/detail?id=2664423048","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664423048?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:27","pubTimestamp":1788391639,"startTime":"0","endTime":"0","summary":"Recursion Pharma director Blake Borgeson disposes of 30,000 shares valued at $100,200Recursion Pharmaceuticals director Blake Borgeson sold 30,000 Class A common shares on Sept. 1, 2026 at $3.34.Direc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbkJccF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Recursion Pharma Director Blake Borgeson Disposes of 30,000 Shares Valued at $100,200","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4609","BK4611","BK4548","BK4539","BK4139","RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165538226","title":"Nvidia Earnings: Six Signals That Matter for the AI Supply Chain","url":"https://stock-news.laohu8.com/highlight/detail?id=1165538226","media":"Earnings Spotlight ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165538226?lang=en_us&edition=fundamental","pubTime":"2026-08-26 11:04","pubTimestamp":1787713478,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://static.tigerbbs.com/87506d5f185d42b9ba5945ac3bba17b4","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/87506d5f185d42b9ba5945ac3bba17b4"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nvidia Earnings: Six Signals That Matter for the AI Supply Chain","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GGLL","GOOG","NNOX","CRWU","NBIZ","CWVX","MSFD","SMCY","GOOW","ORCS","MU","GOOY","ARM","SMCI","NBIL","ORAC","MSFX","ORCL","SMCZ","GS","SMCC","HPEL","MSFU","ARBE","ARMU","GGLS","MSFT","SMCX","HPE","BLK","SOUX","RXRX","NBIS","CRNC","GOU","INVZ","APLZ","ARMW","DLLL","GOOL","GOGL","SMCL","AUR","TM","SERV","BN","MULL","ARMG","ORCU","KKR","MSFY","ORCX","NVDA","SOUN","SMYY","MUU","MUD","ORCZ","GOOGL","MSFO","CRWG","DELL","00992","00860","CWII","NBIG","CRWX","MSFC","NEBX","MUG","MUYY","MSFL","APLX","APLD","MSFW","GOOP","ARMA","CRWV","BX","GOOX","NBIC","MIC","LNVGY","MUZ","CORD"],"isVideo":true,"video":{"duration":636,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/684/render_684_1787712078706.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/684.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/684/tts/voiceover_69b254bd7b8d994b.mp3","isAI":true},"gpt_icon":0},{"id":"1166034224","title":"US Tech Stocks Sell Off Ahead of Nvidia Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1166034224","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166034224?lang=en_us&edition=fundamental","pubTime":"2026-08-25 09:23","pubTimestamp":1787621019,"startTime":"0","endTime":"0","summary":"","market":"sg","thumbnail":"https://static.tigerbbs.com/1815e09373a72d3effc8b713ed6375da","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1815e09373a72d3effc8b713ed6375da"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ba838cf5900a47de94e1e2f5f87b6072","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"US Tech Stocks Sell Off Ahead of Nvidia Earnings","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNXX","SOUX","INYY","NBIZ","TM","ASMZ","WDC","TSMX","APLX","AVGW","MUU","LINT","SNDC","SNDU","TSMY","NBIS","TSM","ARMU","ASML","WDCX","MULL","AMDL","AMUU","07709","AMDD","AMDG","NNOX","AMDW","AVGG","MRVX","DAMD","MUG","09347","TSMG","MVLL","AMDC","SMSD.UK","STX","ARBE","INTW","SNDK","STXU","QCML","SNDQ","ARMW","MRVU","01347","MRVL","WDCC","NBIG","AVGU","MUZ","QCMU","07747","ARM","MIC","STXL","AUR","APLD","TSMU","STXX","TSMZ","SSNLF","TWSC","QCOM","00981","SNDG","QCMD","AVGX","AVL","AMD","RXRX","NBIL","ARMG","AVGO","INTC","SERV","AMDY","NEBX","ARMA","AVS","MUD","ASMG","SOUN","NBIC","AVGC","APLZ","MU","ASMU","STSM","INVZ","NVDA","CRNC","INT","AMYY","MUYY"],"isVideo":true,"video":{"duration":185,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/631/render_631_1787620725199.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/631.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/631/tts/voiceover_51ad1716260eee9e.mp3","isAI":true},"gpt_icon":0},{"id":"1184081263","title":"Nvidia Faces Major Test This Week as AI Market's Bellwether","url":"https://stock-news.laohu8.com/highlight/detail?id=1184081263","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184081263?lang=en_us&edition=fundamental","pubTime":"2026-08-24 08:51","pubTimestamp":1787532702,"startTime":"0","endTime":"0","summary":"","market":"fut","thumbnail":"https://static.tigerbbs.com/55424f784af2130e0629c0c4a06352c9","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/55424f784af2130e0629c0c4a06352c9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ba838cf5900a47de94e1e2f5f87b6072","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nvidia Faces Major Test This Week as AI Market's Bellwether","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEBX","MUZ","ARMW","MUU","ARMA","NNOX","RXRX","MIC","SOUX","ARMU","MUD","INVZ","NBIC","SERV","ARBE","ARMG","NBIZ","NBIL","NBIS","AUR","CRNC","NVDA","MULL","APLD","MU","APLX","ARM","NBIG","MUYY","APLZ","TM","SOUN","MUG"],"isVideo":true,"video":{"duration":204,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/592/render_592_1787532364600.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/592.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/592/tts/voiceover_ff80b9e7919d10e9.mp3","isAI":true},"gpt_icon":0},{"id":"1181557292","title":"Nvidia Q2 FY27 Earnings: Gross Margin, Q3 Guidance in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=1181557292","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181557292?lang=en_us&edition=fundamental","pubTime":"2026-08-21 09:10","pubTimestamp":1787274627,"startTime":"0","endTime":"0","summary":"","market":"sg","thumbnail":"https://static.tigerbbs.com/16c0a892a1297fbe5aa585282447dcb8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/16c0a892a1297fbe5aa585282447dcb8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nvidia Q2 FY27 Earnings: Gross Margin, Q3 Guidance in Focus","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMW","SOUX","NVDS","09388","NBIS","SERV","MUZ","APLX","MUU","SNVDA2609","MUD","MIC","AUR","ARBE","MUG","NNOX","09788","NVDA","NEBX","ARM","MU","NBIZ","07788","INVZ","NBIL","APLD","CRNC","BK4609","07388","RXRX","ARMG","MULL","MUYY","NVD","SOUN","ARMU","TM","NVDL","APLZ"],"isVideo":true,"video":{"duration":136,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/557/render_557_1787274323198.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/557.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/557/tts/voiceover_cd0e5b9e8f315bbc.mp3","isAI":true},"gpt_icon":0}],"profile":{"websiteUrl":"http://www.recursion.com;ir.recursion.com","stockEarnings":[{"period":"1week","weight":0.1599},{"period":"1month","weight":0.1385},{"period":"3month","weight":0.1078},{"period":"6month","weight":0.2585},{"period":"1year","weight":-0.2308},{"period":"ytd","weight":-0.0954}],"compareEarnings":[{"period":"1week","weight":0.0182},{"period":"1month","weight":0.0057},{"period":"3month","weight":0.0456},{"period":"6month","weight":0.2109},{"period":"1year","weight":0.1577},{"period":"ytd","weight":0.126}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 1b/2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer; REC-64151 for the treatment of immune checkpoint resistance; and Anti-PD-(L)1, an orally bioavailable small molecule to improve sensitivity to immune checkpoint inhibitors in non-small cell lung cancer and additional tumors. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.035717},{"month":2,"riseRate":0.4,"avgChangeRate":0.049361},{"month":3,"riseRate":0,"avgChangeRate":-0.249219},{"month":4,"riseRate":0.4,"avgChangeRate":-0.090167},{"month":5,"riseRate":0.5,"avgChangeRate":0.076509},{"month":6,"riseRate":0.666667,"avgChangeRate":0.117519},{"month":7,"riseRate":0.666667,"avgChangeRate":0.141285},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.083252},{"month":9,"riseRate":0.5,"avgChangeRate":-0.027366},{"month":10,"riseRate":0.2,"avgChangeRate":-0.079168},{"month":11,"riseRate":0.4,"avgChangeRate":0.028843},{"month":12,"riseRate":0.2,"avgChangeRate":-0.000986}],"exchange":"NASDAQ","name":"Recursion Pharmaceuticals, Inc.","nameEN":"Recursion Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Recursion Pharmaceuticals, Inc.(RXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Recursion Pharmaceuticals, Inc.(RXRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Recursion Pharmaceuticals, Inc.,RXRX,Recursion Pharmaceuticals, Inc.股票,Recursion Pharmaceuticals, Inc.股票老虎,Recursion Pharmaceuticals, Inc.股票老虎国际,Recursion Pharmaceuticals, Inc.行情,Recursion Pharmaceuticals, Inc.股票行情,Recursion Pharmaceuticals, Inc.股价,Recursion Pharmaceuticals, Inc.股市,Recursion Pharmaceuticals, Inc.股票价格,Recursion Pharmaceuticals, Inc.股票交易,Recursion Pharmaceuticals, Inc.股票购买,Recursion Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Recursion Pharmaceuticals, Inc.(RXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Recursion Pharmaceuticals, Inc.(RXRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}